{"nctId":"NCT00475241","briefTitle":"Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms","startDateStruct":{"date":"2008-01"},"conditions":["Combat Disorders","Posttraumatic Stress Disorder"],"count":36,"armGroups":[{"label":"Prolonged Exposure Therapy","type":"EXPERIMENTAL","interventionNames":["Behavioral: Prolonged Exposure therapy for PTSD"]},{"label":"Present Centered Therapy","type":"ACTIVE_COMPARATOR","interventionNames":["Behavioral: Present centered therapy for PTSD"]}],"interventions":[{"name":"Prolonged Exposure therapy for PTSD","otherNames":[]},{"name":"Present centered therapy for PTSD","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* OEF/OIF Veterans with combat related posttraumatic stress disorder (PTSD) or posttraumatic stress symptoms (PTSS) of at least 3 months duration with significant impairment (PSSI greater than or equal to 15).\n\nExclusion Criteria:\n\n* Any current level of personality disorder or suicidal risk that in the judgment of the investigator makes it unlikely or contraindicated that the patient can adhere to the study regimen.\n* Psychosis\n* Alcohol or substance dependence in the past 3 months\n* Working night-shifts\n* Changes to psychoactive medication in the past 8 weeks\n* Taking medication that makes HPA axis measures difficult to interpret","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Clinician Administered PTSD Scale (Pre & Posttreatment)","description":"Clinician Administered PTSD Scale (CAPS) assesses PTSD symptom severity. Scores range from 0 to 136 and higher scores represent more severe symptoms.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30.0","spread":"18.4"},{"groupId":"OG001","value":"53.6","spread":"28.7"}]}]}]},{"type":"SECONDARY","title":"Trauma Potentiated Startle","description":"Psychophysiological reactivity will be assessed using electromyography collected using a Biopac MP-100 physiology. The potentiation is recorded using a difference score (trauma probe response minus non-trauma probe response).\n\nThe unit of measure is ÂµV. Higher is more response to trauma cue compared to non-trauma cue.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.8","spread":"16.2"},{"groupId":"OG001","value":"19.5","spread":"30.3"}]}]}]},{"type":"SECONDARY","title":"Cortisol Response to Awakening","description":"Area under the curve for awakening, 30 min, and 45 minute salivary cortisol assays.\n\nHigher means more cortisol response to awakening detected.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.2","spread":".4"},{"groupId":"OG001","value":".5","spread":".4"}]}]}]},{"type":"SECONDARY","title":"Posttraumatic Cognitions Inventory","description":"Self-report measure of trauma-related cognitions. Range is 21-147. Higher is more problematic trauma-related cognitions.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"91.3","spread":"41.9"},{"groupId":"OG001","value":"97.1","spread":"45.6"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":11},"commonTop":[]}}}